ID   IHL,AD036
AC   CVCL_E709
SY   IHL, AD036; TER235; TER-225; Ter 235; TER279; TER-279; Ter 279; TER421; TER-421; Ter 421; Extract 89; Extract 188
DR   dbMHC; 48905
DR   ECACC; 94082223
DR   IHW; IHW09124
DR   IPD-IMGT/HLA; 10797
DR   Wikidata; Q54897415
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Aboriginal Australian.
CC   HLA typing: A*02:01:01:01,34:01:01; B*40:02:01,56:02; C*01:02:01,15:02:01:01; DPB1*02:01:02,02:01:02; DQA1*01:03,01:04:01:02; DQB1*05:03:01,06:01:01; DRB1*08:03:02,14:14; DRB3*02:02 (IPD-IMGT/HLA=10797).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
RX   PubMed=8307784; DOI=10.1016/0198-8859(93)90514-2;
RA   Degli-Esposti M.A., Griffiths M.S.J., Daly L.N., Witt C.S., Simons M.,
RA   Carcassi C., Albert E.D., Giphart M.J., Dawkins R.L.;
RT   "Characterization of 4AOHW cell line panel including new data for the
RT   10IHW panel.";
RL   Hum. Immunol. 38:3-16(1993).